BioLife Solutions, Inc. Gross Profit
BioLife Solutions, Inc. (BLFS) reported Gross Profit of $18.29 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement
us-gaap:GrossProfit · last filed 2026-08-06
- BioLife Solutions, Inc. gross profit for the quarter ending 2026-06-30 was $18.29M, a 20.03% increase year-over-year.
- BioLife Solutions, Inc. gross profit for the quarter ending 2026-03-31 was $17.50M, a 18.22% increase year-over-year.
- BioLife Solutions, Inc. gross profit for the quarter ending 2025-06-30 was $15.23M.
- BioLife Solutions, Inc. gross profit for the quarter ending 2025-03-31 was $14.80M.
- BioLife Solutions, Inc. gross profit for fiscal 2025 was $62.12M, a 24.00% increase from fiscal 2024.
- BioLife Solutions, Inc. gross profit for fiscal 2024 was $50.10M, a 21.24% increase from fiscal 2023.
- BioLife Solutions, Inc. gross profit for fiscal 2023 was $41.32M.
- BioLife Solutions, Inc. gross profit for fiscal 2018 was $13.53M, a 100.49% increase from fiscal 2017.
| Period end | Gross Profit 3 month | Gross Profit 3 month as first filed | Gross Profit 6 month | Gross Profit 6 month as first filed | Gross Profit 9 month | Gross Profit 9 month as first filed | Gross Profit 12 month | Gross Profit 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $18.29M 10-Q · filed 2026-08-06 | $35.78M 10-Q · filed 2026-08-06 | ||||||
| 2026-03-31 | $17.50M 10-Q · filed 2026-05-07 | |||||||
| 2025-12-31 | $62.12M 10-K · filed 2026-02-26 | |||||||
| 2025-06-30 | $15.23M 10-Q · filed 2026-08-06 | $30.04M 10-Q · filed 2026-08-06 | ||||||
| 2025-03-31 | $14.80M 10-Q · filed 2026-05-07 | |||||||
| 2024-12-31 | $50.10M 10-K · filed 2026-02-26 | |||||||
| 2023-12-31 | $41.32M 10-K · filed 2026-02-26 | |||||||
| 2019-09-30 | $4.52M 10-Q · filed 2019-11-12 | $9.26M derived: sum of 2 quarters · filed 2019-11-12 | $13.38M 10-Q · filed 2019-11-12 | $17.13M derived: sum of 4 quarters · filed 2019-11-12 | ||||
| 2019-06-30 | $4.74M 10-Q · filed 2019-08-09 | $8.87M 10-Q · filed 2019-08-09 | $12.61M derived: sum of 3 quarters · filed 2019-08-09 | $16.30M derived: sum of 4 quarters · filed 2019-11-12 | ||||
| 2019-03-31 | $4.12M 10-Q · filed 2019-05-09 | $7.87M derived: sum of 2 quarters · filed 2019-05-09 | $11.56M derived: sum of 3 quarters · filed 2019-11-12 | $15.20M derived: sum of 4 quarters · filed 2019-11-12 | ||||
| 2018-12-31 | $3.75M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $7.43M derived: sum of 2 quarters · filed 2019-11-12 | $11.07M derived: sum of 3 quarters · filed 2019-11-12 | $13.53M 10-K · filed 2019-03-15 | ||||
| 2018-09-30 | $3.69M 10-Q · filed 2019-11-12 | $3.69M 10-Q · filed 2018-11-08 | $7.33M derived: sum of 2 quarters · filed 2019-11-12 | $9.78M 10-Q · filed 2019-11-12 | $9.78M 10-Q · filed 2018-11-08 | $11.62M derived: sum of 4 quarters · filed 2019-11-12 | ||
| 2018-06-30 | $3.64M 10-Q · filed 2019-08-09 | $3.64M 10-Q · filed 2018-08-09 | $6.09M 10-Q · filed 2019-08-09 | $6.09M 10-Q · filed 2018-08-09 | $7.93M derived: sum of 3 quarters · filed 2019-08-09 | $9.80M derived: sum of 4 quarters · filed 2019-08-09 | ||
| 2018-03-31 | $2.45M 10-Q · filed 2019-05-09 | $2.45M 10-Q · filed 2018-05-11 | $4.29M derived: sum of 2 quarters · filed 2019-05-09 | $6.16M derived: sum of 3 quarters · filed 2019-05-09 | $7.76M derived: sum of 4 quarters · filed 2019-05-09 | |||
| 2017-12-31 | $1.84M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $3.71M derived: sum of 2 quarters · filed 2019-03-15 | $5.31M derived: sum of 3 quarters · filed 2019-03-15 | $6.75M 10-K · filed 2019-03-15 | $6.75M 10-K · filed 2018-03-09 | |||
| 2017-09-30 | $1.87M 10-Q · filed 2018-11-08 | $3.47M derived: sum of 2 quarters · filed 2018-11-08 | $4.91M 10-Q · filed 2018-11-08 | $6.27M derived: sum of 4 quarters · filed 2018-11-08 | ||||
| 2017-06-30 | $1.60M 10-Q · filed 2018-08-09 | $3.04M 10-Q · filed 2018-08-09 | $4.40M derived: sum of 3 quarters · filed 2018-08-09 | $5.62M derived: sum of 4 quarters · filed 2018-08-09 | ||||
| 2017-03-31 | $1.44M 10-Q · filed 2018-05-11 | $2.80M derived: sum of 2 quarters · filed 2018-05-11 | $4.02M derived: sum of 3 quarters · filed 2018-05-11 | $5.14M derived: sum of 4 quarters · filed 2018-05-11 | ||||
| 2016-12-31 | $1.37M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $2.58M derived: sum of 2 quarters · filed 2018-03-09 | $3.70M derived: sum of 3 quarters · filed 2018-03-09 | $4.78M 10-K · filed 2018-03-09 | ||||
| 2016-09-30 | $1.21M 10-Q · filed 2017-11-09 | $2.33M derived: sum of 2 quarters · filed 2017-11-09 | $3.41M 10-Q · filed 2017-11-09 | $4.55M derived: sum of 4 quarters · filed 2017-11-09 | ||||
| 2016-06-30 | $1.12M 10-Q · filed 2017-08-11 | $2.20M 10-Q · filed 2017-08-11 | $3.34M derived: sum of 3 quarters · filed 2017-08-11 | $4.31M derived: sum of 4 quarters · filed 2017-08-11 | ||||
| 2016-03-31 | $1.08M 10-Q · filed 2017-05-12 | $2.22M derived: sum of 2 quarters · filed 2017-05-12 | $3.19M derived: sum of 3 quarters · filed 2017-05-12 | $4.01M derived: sum of 4 quarters · filed 2017-05-12 | ||||
| 2015-12-31 | $1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $2.11M derived: sum of 2 quarters · filed 2017-03-15 | $2.93M derived: sum of 3 quarters · filed 2017-03-15 | $3.81M 10-K · filed 2017-03-15 | ||||
| 2015-09-30 | $973.38K 10-Q · filed 2016-11-10 | $1.79M derived: sum of 2 quarters · filed 2016-11-10 | $2.67M 10-Q · filed 2016-11-10 | $3.67M derived: sum of 4 quarters · filed 2016-11-10 | ||||
| 2015-06-30 | $818.65K 10-Q · filed 2016-08-11 | $1.70M 10-Q · filed 2016-08-11 | $2.70M derived: sum of 3 quarters · filed 2016-08-11 | $3.29M derived: sum of 4 quarters · filed 2016-08-11 | ||||
| 2015-03-31 | $882.62K 10-Q · filed 2016-05-16 | $1.88M derived: sum of 2 quarters · filed 2016-05-16 | $2.47M derived: sum of 3 quarters · filed 2016-05-16 | $3.01M derived: sum of 4 quarters · filed 2016-05-16 | ||||
| 2014-12-31 | $998.31K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $1.59M derived: sum of 2 quarters · filed 2016-02-25 | $2.13M derived: sum of 3 quarters · filed 2016-02-25 | $3.04M 10-K · filed 2016-02-25 | ||||
| 2014-09-30 | $588.39K 10-Q · filed 2015-11-16 | $1.13M derived: sum of 2 quarters · filed 2015-11-16 | $2.04M 10-Q · filed 2015-11-16 | $2.96M derived: sum of 4 quarters · filed 2015-11-16 | ||||
| 2014-06-30 | $545.32K 10-Q · filed 2015-08-06 | $1.45M 10-Q · filed 2015-08-06 | $2.37M derived: sum of 3 quarters · filed 2015-08-06 | $3.26M derived: sum of 4 quarters · filed 2015-08-06 | ||||
| 2014-03-31 | $903.39K 10-Q · filed 2015-05-07 | $1.82M derived: sum of 2 quarters · filed 2015-05-07 | $2.71M derived: sum of 3 quarters · filed 2015-05-07 | $3.54M derived: sum of 4 quarters · filed 2015-05-07 | ||||
| 2013-12-31 | $920.10K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $1.81M derived: sum of 2 quarters · filed 2015-03-12 | $2.64M derived: sum of 3 quarters · filed 2015-03-12 | $3.76M 10-K · filed 2015-03-12 | ||||
| 2013-09-30 | $888.86K 10-Q · filed 2014-11-06 | $1.72M derived: sum of 2 quarters · filed 2014-11-06 | $2.84M 10-Q · filed 2014-11-06 | $3.59M derived: sum of 4 quarters · filed 2014-11-06 | ||||
| 2013-06-30 | $828.44K 10-Q · filed 2014-08-07 | $1.95M 10-Q · filed 2014-08-07 | $2.71M derived: sum of 3 quarters · filed 2014-08-07 | $3.30M derived: sum of 4 quarters · filed 2014-08-07 | ||||
| 2013-03-31 | $1.13M 10-Q · filed 2014-05-08 | $1.88M derived: sum of 2 quarters · filed 2014-05-08 | $2.47M derived: sum of 3 quarters · filed 2014-05-08 | $2.93M derived: sum of 4 quarters · filed 2014-05-08 | ||||
| 2012-12-31 | $751.56K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-12 | $1.35M derived: sum of 2 quarters · filed 2014-02-12 | $1.80M derived: sum of 3 quarters · filed 2014-02-12 | $2.29M 10-K · filed 2014-02-12 | ||||
| 2012-09-30 | $595.45K 10-Q · filed 2013-11-14 | $1.05M derived: sum of 2 quarters · filed 2013-11-14 | $1.54M 10-Q · filed 2013-11-14 | $2.00M derived: sum of 4 quarters · filed 2013-11-14 | ||||
| 2012-06-30 | $455.66K 10-Q · filed 2013-08-12 | $945.41K 10-Q · filed 2013-08-12 | $1.40M derived: sum of 3 quarters · filed 2013-08-12 | $1.77M derived: sum of 4 quarters · filed 2013-08-12 | ||||
| 2012-03-31 | $489.75K 10-Q · filed 2013-05-14 | $946.82K derived: sum of 2 quarters · filed 2013-05-14 | $1.32M derived: sum of 3 quarters · filed 2013-05-14 | $1.65M derived: sum of 4 quarters · filed 2013-05-14 | ||||
| 2011-12-31 | $457.06K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-29 | $827.03K derived: sum of 2 quarters · filed 2013-03-29 | $1.16M derived: sum of 3 quarters · filed 2013-03-29 | $1.40M 10-K · filed 2013-03-29 | ||||
| 2011-09-30 | $369.96K 10-Q · filed 2012-11-13 | $703.89K derived: sum of 2 quarters · filed 2012-11-13 | $946.09K 10-Q · filed 2012-11-13 | $1.15M derived: sum of 4 quarters · filed 2012-11-13 | ||||
| 2011-06-30 | $333.93K 10-Q · filed 2012-08-14 | $576.13K 10-Q · filed 2012-08-14 | $783.40K derived: sum of 3 quarters · filed 2012-08-14 | $1.01M derived: sum of 4 quarters · filed 2012-08-14 | ||||
| 2011-03-31 | $242.20K 10-Q · filed 2012-05-14 | $449.47K derived: sum of 2 quarters · filed 2012-05-14 | $674.31K derived: sum of 3 quarters · filed 2012-05-14 | $867.93K derived: sum of 4 quarters · filed 2012-05-14 | ||||
| 2010-12-31 | $207.27K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29 | $432.12K derived: sum of 2 quarters · filed 2012-03-29 | $625.73K derived: sum of 3 quarters · filed 2012-03-29 | $856.39K 10-K · filed 2012-03-29 | ||||
| 2010-09-30 | $224.84K 10-Q · filed 2011-11-14 | $418.46K derived: sum of 2 quarters · filed 2011-11-14 | $649.12K 10-Q · filed 2011-11-14 | |||||
| 2010-06-30 | $193.62K 10-Q · filed 2011-08-12 | $432.34K 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |